Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-blind Multicenter, Randomized Controlled Trial of Single and Multiple Dose Regimens of Oxfendazole for Mild (One or Two Lesions) Parenchymal Brain Cysticercosis, With an Open Comparison Group

NCT06565507 is registered in ClinicalTrials.gov with Universidad Peruana Cayetano Heredia as lead sponsor.

NCT NCT06565507
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06565507 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-blind Multicenter, Randomized Controlled Trial of Single and Multiple Dose Regimens of Oxfendazole for Mild (One or Two Lesions) Parenchymal Brain Cysticercosis, With an Open Comparison Group
Lead sponsor
Universidad Peruana Cayetano Heredia
Phase
Phase 2/3
Overall status
Not yet recruiting
Start date
December 1, 2026
Completion date
December 15, 2030
Enrollment
544 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

brain cysticercosis